Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AngioDynamics injunction

This article was originally published in The Gray Sheet

Executive Summary

AngioDynamics will begin shipping NeverTouch VenaCure varicose vein laser treatment procedure kits June 2 to replace orders for its VenaCure laser following a ruling in Boston Federal District Court upholding a March jury verdict that VenaCure infringes on a Diomed patent for the EndoVenous laser system (1"The Gray Sheet" April 16, 2007, p. 16). The court ruled May 22 that Diomed is entitled to a permanent injunction, and instructed both parties to agree upon specific terms by May 29. In addition, the verdict orders AngioDynamics to pay an additional $1.35 million in damages to cover pretrial interest and post verdict sales of VenaCure, bringing total damages against the company to $9.71 million. AngioDynamics stopped shipment of VenaCure April 27...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024834

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel